Phase 4Completed
Effects of Acarbose Versus Glibenclamide on MAGE and Oxidative Stress in Patients With Type 2 DM
Phase 4 Study Evaluation of the Effects of Acarbose Versus Glibenclamide on Mean Amplitude of Glycemic Excursions and Oxidative Stress in Patients With Type 2 Diabetes Insufficiently Controlled by Metformin
- Sponsor
- Taichung Veterans General Hospital (Academic or other)
- Enrollment
- 51 enrolled
- Conditions
- Diabetes Mellitus
- Interventions
- Acarbose
- Ages
- adults, older adults
- Registry
- NCT00417729
Full record on ClinicalTrials.gov
From the registry
To compare effect of acarbose versus glibenclamide treatment on mean amplitude of glyclemic excursion and oxidative stress in diabetes individuals who failed to control their glucose by metformin therapy alone
Primary outcomes
- Mean Amplitude Glycemic Excursion
- Oxidative stress
History
Last registry update
Primary completion
Started
Registered